Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
MEDIACE
- Development stage
- Preclinical
- Lead developer
- AMS BioteQ
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
MEDIACE is a natural antimicrobial wound dressing developed by AMS BioteQ. It utilizes a proprietary component called AirAce, which contains antibacterial compounds extracted from the medicinal fungus *Antrodia camphorata* via the patented ExtrO technology. The dressing is constructed from a gelatin-based material that is highly absorbent, non-adhesive, and possesses anti-inflammatory properties. Designed for topical application, MEDIACE is intended for the treatment of wounds with varying levels of exudate, specifically targeting diabetic ulcers, bedsores, and burns. It is engineered to promote early wound healing with an efficacy profile comparable to silver-based dressings but with reduced side effects.
- Brand names
- MEDIACE
- Other names
- AirAceAntrodia camphorata extract
02
Targets
PGT (Peptidoglycan glycosyltransferase)
Beyond the preview
Go deeper on MEDIACE.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MEDIACE.